Highlights • MRI/TRUS fusion TP PBx clinically significant prostate cancer detection rates were consistent across the chronological quintiles. • Procedure time significantly reduced from a median of 46 to 19…

Highlights • The hybrid model designed in this study could serve as an alternative tool for noninvasive progression-free survival prediction of ccRCC patients. • The predictive performance of habitat imaging-based…

Highlights • Tumor size has a higher predictive ability for prognosis in IOIO therapy compared to IOTKI. • Time-dependent AUC analysis shows tumor size consistently predicts PFS and OS in…

Abstract Objectives Microwave ablation (MWA) has gained attention as a minimally invasive and safe alternative to surgical intervention for patients with small renal masses; however, its cost-effectiveness in Australia remains…

Highlights • Standard transperitoneal procedure is associated with high complication rates. • Indications: elderly, frail, high risk patients. • Second primary in the bladder with solitary functioning kidney. • Complete…

Highlights • Immediate postoperative intravesical chemotherapy is underutilized. • No demonstrated risk of complications exists following its use. • Elective surgery and shorter operative times are associated with higher utilization….

Highlights • No population-based study validated the survival benefit of neoadjuvant chemotherapy recorded in clinical trials in a stage-specific fashion. • The current study represents the only retrospective analysis that…

Highlights • Controversy remains regarding adjuvant therapy (AT) in patients treated with neoadjuvant chemotherapy (NAC) and radical cystectomy (RC) for muscle-invasive bladder cancer. • Determining variables that may affect cancer-specific…

Highlights • In the absence of evidence from randomized controlled trials, Trimodal Therapy (TMT) for muscle-invasive bladder cancer (MIBC) is usually reserved to patients with poor overall health status. •…